IMARC Group's report titled "Hematologic Malignancies Market Report by Type (Leukemia, Lymphoma, Multiple Myeloma, and Others), Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), End User (Hospitals, Diagnostics Centers, Research Centers, and Others), and Region 2024-2032". The global hematologic malignancies market size reached US$ 60.3 Billion in...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian